{"nct_id":"NCT04410445","title":"Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence","status":"TERMINATED","status_verified_date":"2023-03","start_date":"2020-07-27","start_date_type":"ACTUAL","primary_completion_date":"2022-09-22","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NKTR"]}